[1] Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior[J]. Neurogastroenterol Motil, 2011, 23(3): 187-192.
[2] Montiel-Castro AJ, González-Cervantes RM, Gabriela BR, et al.The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality[J]. Front Integr Neurosci, 2013, 7: 70.
[3] Mayer EA, Knight R, Mazmanian SK, et al.Gut microbes and the brain: paradigm shift in neuroscience[J]. J Neurosci, 2014, 34(46): 15490-15496.
[4] Wang Y, Kasper LH.The role of microbiome in central nervous system disorders[J]. Brain Behav Immun, 2014, 38: 1-12.
[5] Mayer EA, Tillisch K, Gupta A.Gut/brain axis and the microbiota[J]. J Clin Invest, 2015, 125(3): 926-938.
[6] 王文建,郑跃杰. 肠道菌群与中枢神经系统相互作用及相关疾病[J]. 中国微生态学杂志, 2016, 28(2): 240-245.
[7] Kang DW, Jin GP, Ilhan ZE, et al.Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children[J]. PLoS One, 2013, 8(7): e68322.
[8] Ghaisas S, Maher J, Kanthasamy A.Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases[J]. Pharmacol Ther, 2016, 158: 52-62.
[9] Evans JM, Morris LS, Marchesi JR.The gut microbiome: the role of a virtual organ in the endocrinology of the host[J]. J Endocrinol, 2013, 218(3): R37-R47.
[10] Matsumoto M, Kibe R, Ooga T, et al.Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study[J]. Front Syst Neurosci, 2013, 7: 9.
[11] Keightley PC, Koloski NA, Talley NJ.Pathways in gut-brain communication: Evidence for distinct gut-to-brain and brain-to-gut syndromes[J]. Aust N Z J Psychiatry, 2015, 49(3): 207-214.
[12] Feng Q, Chen WD, Wang YD.Gut microbiota: an integral moderator in health and disease[J]. Front Microbiol, 2018, 9: 151.
[13] 李学军,高燕洁,孟繁兴,等. 脑卒中急性期脑肠肽变化的研究[J]. 吉林中医药, 2012, 32(11): 1113-1115.
[14] Wall R, Cryan JF, Ross RP, et al.Bacterial neuroactive compounds produced by psychobiotics[J]. Adv Exp Med Biol, 2014, 817: 221-239.
[15] Iadecola C, Anrather J.The immunology of stroke: from mechanisms to translation[J]. Nat Med, 2011, 17(7): 796-808.
[16] Mazmanian SK, Liu CH, Tzianabos AO, et al.An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system[J]. Cell, 2005, 122(1):107-118.
[17] Prinz I, Silva-Santos B, Pennington DJ.Functional development of γδ T cells[J]. Eur J Immunol, 2013, 43(8): 1988-1994.
[18] Shichita T, Sugiyama Y, Ooboshi H, et al.Pivotal role of cerebral interleukin-17-producing gamma delta T cells in the delayed phase of ischemic brain injury[J]. Nat Med, 2009, 15(8): 946-950.
[19] Benakis C, Brea D, Caballero S, et al.Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells[J]. Nat Med, 2016, 22(5): 516-523.
[20] Svensson E, Horváthpuhó E, Thomsen RW, et al.Vagotomy and subsequent risk of Parkinson's disease[J]. Ann Neurol, 2015, 78(4): 522-529.
[21] Scheperjans F, Aho V, Pereira PA, et al.Gut microbiota are related to Parkinson's disease and clinical phenotype[J]. Mov Disord, 2015, 30(3): 350-358.
[22] Montine TJ, Li K, Perl DP, et al.Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC[J]. Neurology, 2005, 65(5): 768-769.
[23] Bravo JA, Forsythe P, Chew MV, et al.Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve[J]. Proc Natl Acad Sci U S A, 2011, 108(38): 16050-16055.
[24] Hill JM, Bhattacharjee S, Pogue AI, et al.The gastrointestinal tract microbiome and potential link to Alzheimer's disease[J]. Front Neurol, 2014, 5: 43.
[25] Bhattacharjee S, Lukiw WJ.Alzheimer's disease and the microbiome[J]. Front Cell Neurosci, 2013, 7(4): 153.
[26] Alam MZ, Alam Q, Kamal MA, et al.A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update[J]. CNS Neurol Disord Drug Targets, 2014, 13(3): 383-390.
[27] Clarke G, Grenham S, Scully P, et al.The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner[J]. Mol Psychiatry, 2013, 18(6): 666-673.
[28] Mielcarz DW, Kasper LH.The gut microbiome in multiple sclerosis[J]. Curr Treat Options Neurol, 2015, 17(4): 344.
[29] Joscelyn J, Kasper LH.Digesting the emerging role for the gut microbiome in central nervous system demyelination[J]. Mult Scler, 2014, 20(12): 1553-1559.
[30] Berer K, Mues M, Koutrolos M, et al.Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination[J]. Nature, 2011, 479(7374): 538-541.
[31] von Geldern G, Mowry EM. The influence of nutritional factors on the prognosis of multiple sclerosis[J]. Nat Rev Neurol, 2012, 8(12): 678-689.
[32] Cox LM, Weiner HL.Microbiota signaling pathways that influence neurologic disease[J]. Neurotherapeutics, 2018, 15(1): 135-145.
[33] Riccio P, Rossano R.Nutrition facts in multiple sclerosis[J]. ASN Neuro, 2015, 7(1): 1759091414568185.
[34] Liu Q, Duan ZP, Ha DK, et al.Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis[J]. Hepatology, 2004, 39(5): 1441-1449.
[35] Chen Y, Yang F, Lu H, et al.Characterization of fecal microbial communities in patients with liver cirrhosis[J]. Hepatology, 2011, 54(2): 562-572.
[36] Bajaj JS, Hylemon PB, Ridlon JM, et al.Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 303(6): G675-G685.
[37] Mittal VV, Sharma BC, Sharma P, et al.A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy[J]. Eur J Gastroenterol Hepatol, 2011, 23(8): 725-732.
[38] Garcovich M, Zocco MA, Roccarina D, et al.Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota[J]. World J Gastroenterol, 2012, 18(46): 6693-6700.
[39] Dhiman RK.Gut microbiota and hepatic encephalopathy[J]. Metab Brain Dis, 2013, 28(2): 321-326.
[40] Rai R, Saraswat VA, Dhiman RK.Gut microbiota: its role in hepatic encephalopathy[J]. J Clin Exp Hepatol, 2015, 5(Suppl 1): S29-S36.
[41] Minemura M, Shimizu Y.Gut microbiota and liver diseases[J]. World J Gastroenterol, 2015, 21(6): 1691-1702.
[42] Wang L, Conlon MA, Christophersen CT, et al.Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders[J]. Biomark Med, 2014, 8(3): 331-344.
[43] Licinio J, Mastronardi C, Wong ML.Pharmacogenomics of neuroimmune interactions in human psychiatric disorders[J]. Exp Physiol, 2007, 92(5): 807-811.
[44] 王振,肖泽萍,陈珏,等. 焦虑症的生化病理机制探讨[J]. 临床精神医学杂志, 2003, 13(1): 1-3.
[45] Sudo N.Stress and gut microbiota: Does postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response?[J]. International Congress, 2006, 1287: 350-354.
[46] Desbonnet L, Garrett L, Clarke G, et al.The probiotic bifidobacteria infantis: an assessment of potential antidepressant properties in the rat[J]. J Psychiatr Res, 2008, 43(2): 164-174.
[47] O'Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment[J]. Hum Psychopharmacol, 2004, 19(6): 397-403.
[48] Patel R, Dupont HL.New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics[J]. Clin Infect Dis, 2015, 60(Suppl 2): S108-S121.
[49] Borody TJ, Paramsothy S, Agrawal G.Fecal microbiota transplantation: indications, methods, evidence, and future directions[J]. Curr Gastroenterol Rep, 2013, 15(8): 337.
[50] Smits LP, Bouter KE, de Vos WM, et al. Therapeutic potential of fecal microbiota transplantation[J]. Gastroenterology, 2013, 145(5): 946-953.
[51] Xu MQ, Cao HL, Wang WQ, et al.Fecal microbiota transplantation broadening its application beyond intestinal disorders[J]. World J Gastroenterol, 2015, 21(1): 102-111.
[52] de Vrieze J. Medical research. The promise of poop[J]. Science, 2013, 341(6149): 954-957.
[53] Matsumoto M, Inoue R, Tsukahara T, et al.Voluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecum[J]. Biosci Biotechnol Biochem, 2008, 72(2): 572-576.
[54] Clarke SF, Murphy EF, O'Sullivan O, et al. Exercise and associated dietary extremes impact on gut microbial diversity[J]. Gut, 2014, 63(12): 1913-1920.
[55] 丁硕. 九种健脾胃中草药对三种典型益生菌体外生长及溃疡性结肠炎大鼠的影响[D]. 保定,秦皇岛,沧州:河北农业大学, 2013.
[56] 李娟,李晓东,杨丽霞,等. 单味中药体外抑菌活性的研究进展[J]. 中国实验方剂学杂志, 2011, 17(11): 283-286.
[57] 刘晋仙,林永强,汪冰,等. 中药促进益生菌生长的研究进展[J]. 药学研究, 2015(9): 537-538.
[58] Jin Y, Zhao Q, Zhou K, et al.Acupuncture for functional dyspepsia: a single blinded, randomized, controlled trial[J]. Evid Based Complement Alternat Med, 2015, 2015: 904926.
[59] Li G, Li S, Wang B, et al.The effect of electroacupuncture on postoperative immunoinflammatory response in patients undergoing supratentorial craniotomy[J]. Exp Ther Med, 2013, 6(3): 699-702.
[60] Ma XP, Hong J, An CP, et al.Acupuncture-moxibustion in treating irritable bowel syndrome: How does it work?[J]. World J Gastroenterol, 2014, 20(20): 6044-6054.
[61] Wang XM, Lu Y, Wu LY, et al.Moxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitis[J]. World J Gastroenterol, 2012, 18(46): 6819-6828.
[62] 杨玥,张丹华,陈媛,等. 脑肠互动与针刺治疗功能性胃肠病的相关性[J]. 世界华人消化杂志, 2012, 20(6): 491-496.
[63] 蒋龙龙,刘昱材,李学超,等. 捏脊疗法作用机制及作用特点探讨[J]. 中华中医药杂志, 2015, 30(8): 2852-2856.
[64] 熊英,沈楚楚,樊璞,等. 捏脊法对脾虚哮喘大鼠肠道菌群和肺部炎症的影响[J]. 中医杂志, 2018, 59(1): 61-65.
